Currencies / NVS
NVS: Novartis AG
116.98
USD
0.20
(0.17%)
NVS exchange rate has changed by -0.17% for today. During the day, the instrument was traded at a low of 116.95 and at a high of 117.60.
Follow Novartis AG dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
NVS News
- Seeking Alpha The Play On TG Therapeutics (NASDAQ:TGTX)
- Seeking Alpha Merck Stock Is Almost A Classical Benjamin Graham Investment
- Zacks INCY's Q2 Earnings & Revenues Beat Estimates on Higher Product Sales
- Seeking Alpha Franklin Mutual International Value Fund Q2 2025 Commentary
- Seeking Alpha Fidelity Overseas Fund Q2 2025 Commentary (Mutual Fund:FOSFX)
- Seeking Alpha Franklin Mutual Global Discovery Fund Q2 2025 Commentary
- Seeking Alpha Fidelity International Capital Appreciation Fund Q2 2025 Commentary (Mutual Fund:FIVFX)
- Benzinga Sarepta Gets Thumbs Down From Regulators Regarding Gene Therapy - Sarepta Therapeutics (NASDAQ:SRPT)
- Investor's Business Daily The Hits Keep Coming For Sarepta. Why Its Latest Setback Creates A 'Dangerous Precedent.'
- Zacks Incyte Gears Up to Report Q2 Earnings: Is a Beat in the Cards?
- Zacks Here's Why Novartis (NVS) is a Strong Value Stock
- Zacks Why Investors Need to Take Advantage of These 2 Medical Stocks Now
- Seeking Alpha Dodge & Cox International Stock Fund Q2 2025 Shareholder Letter
- Benzinga Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US - AstraZeneca (NASDAQ:AZN)
- Zacks AZN Commits USD50B to US Manufacturing Expansion Amid Tariff Pressures
- The Motley Fool Highest Ever for This International Stock ETF -- But Analysts Say It Has Room to Run
- Zacks Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
- Zacks Betting Big on Cancer: 3 Oncology Stocks Set to Surge in 2025
- Seeking Alpha Novartis AG 2025 Q2 - Results - Earnings Call Presentation (NYSE:NVS)
- Seeking Alpha Novartis AG (NVS) Q2 2025 Earnings Call Transcript
- The Motley Fool Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.
- Zacks Buy These 5 Low-Leverage Stocks Amid Impressive Retail Sales Data
- Seeking Alpha Takeda: Positioned To Tackle Future Clinical Demand In A Highly Regulated Sector (TAK)
- Zacks Novartis Beats on Q2 Earnings and Sales, CFO Retires, Stock Down
Daily Range
116.95
117.60
Year Range
96.06
124.82
- Previous Close
- 117.17
- Open
- 117.18
- Bid
- 116.98
- Ask
- 117.28
- Low
- 116.95
- High
- 117.60
- Volume
- 1.651 K
- Daily Change
- -0.17%
- Month Change
- -4.19%
- 6 Months Change
- 11.95%
- Year Change
- 4.55%
30 July, Wednesday
12:15
USD
- Act
- 104 K
- Fcst
- 57 K
- Prev
- -33 K
12:30
USD
- Act
- 3.0%
- Fcst
- 0.4%
- Prev
- -0.5%
12:30
USD
- Act
- 2.0%
- Fcst
- 3.6%
- Prev
- 3.8%
12:30
USD
- Act
- 2.5%
- Fcst
- 3.3%
- Prev
- 3.5%
12:30
USD
- Act
- 2.1%
- Fcst
- 3.1%
- Prev
- 3.7%
12:30
USD
- Act
- 1.4%
- Fcst
- 0.8%
- Prev
- 0.5%
12:30
USD
- Act
- 6.3%
- Fcst
- -1.5%
- Prev
- -3.1%
14:00
USD
- Act
- -0.8%
- Fcst
- 1.6%
- Prev
- 1.8%
14:00
USD
- Act
- -2.8%
- Fcst
- 9.6%
- Prev
- 1.1%
14:00
USD
- Act
- 72.0
- Fcst
- Prev
- 72.6
14:30
USD
- Act
- 7.698 M
- Fcst
- 0.914 M
- Prev
- -3.169 M
14:30
USD
- Act
- 0.690 M
- Fcst
- 0.114 M
- Prev
- 0.455 M
14:30
USD
- Act
- 1.317 M
- Fcst
- 0.738 M
- Prev
- -0.740 M
14:30
USD
- Act
- 0.130 M
- Fcst
- -0.004 M
- Prev
- 0.095 M
14:30
USD
- Act
- 3.635 M
- Fcst
- -0.111 M
- Prev
- 2.931 M
14:30
USD
- Act
- 0.676 M
- Fcst
- 0.915 M
- Prev
- 0.282 M
14:30
USD
- Act
- 0.739 M
- Fcst
- 0.608 M
- Prev
- 0.003 M
14:30
USD
- Act
- -2.724 M
- Fcst
- 0.879 M
- Prev
- -1.738 M
14:30
USD
- Act
- -0.025 M
- Fcst
- Prev
- 0.087 M
14:30
USD
- Act
- -0.1%
- Fcst
- Prev
- 1.6%
18:00
USD
- Act
- Fcst
- Prev
18:00
USD
- Act
- 4.50%
- Fcst
- Prev
- 4.50%
18:30
USD
- Act
- Fcst
- Prev